Valuation : Cegedim

Market Cap 143M 166M 134M 123M 229M 15.72B 231M 1.59B 619M 8.03B 624M 611M 25.87B P/E 2026 *
6.83x
P/E 2027 * 5.21x
Enterprise Value 305M 355M 286M 262M 489M 33.53B 493M 3.39B 1.32B 17.14B 1.33B 1.3B 55.19B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.58%
1 week+0.78%
1 month-1.33%
3 months-9.28%
6 months-0.38%
Current year-23.54%
1 week 10.2
Extreme 10.2
10.5
1 month 10.1
Extreme 10.1
10.76
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
20.65
5 years 8.5
Extreme 8.5
29.25
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 24/10/2009
Director of Finance/CFO - 13/06/2016
Corporate Officer/Principal 55 25/11/2015
Director TitleAgeSince
Chairman 83 24/10/2009
Director/Board Member 72 08/08/2010
Director/Board Member 55 25/10/2009
Date Insider Type Main position Quantity % Market Cap. Importance
30/04/26 Buy 751 0.0053%
28/04/26 Buy 74,537 0.5287%
16/04/26 Buy 500 0.0035%
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%+0.78%-0.38%-49.34% 166M
+5.36%+1.73%-30.83%+24.67% 420B
+2.28%-2.26%-19.78%+44.98% 243B
+5.68%+4.18%-21.57%+20.75% 141B
+14.81%+2.38%-57.41%+302.76% 47.33B
+1.11%-1.62%-33.21%+8.64% 46.66B
+1.67%-4.16%-27.08%+24.23% 23.75B
-0.04%-3.51%-20.06%+56.60% 19.68B
+4.51%-0.45%-8.70%+132.58% 16.05B
+1.41%-2.78%-23.88%+11.89% 13.78B
Average +3.66%-0.36%-24.29%+57.78% 97.13B
Weighted average by Cap. +4.75%+0.29%-27.35%+44.18%

Financials

2026 *2027 *
Net sales 660M 767M 619M 566M 1.06B 72.46B 1.07B 7.32B 2.85B 37.03B 2.88B 2.82B 119B 684M 795M 642M 587M 1.1B 75.16B 1.1B 7.59B 2.96B 38.41B 2.99B 2.92B 124B
Net income 21.3M 24.76M 19.99M 18.29M 34.13M 2.34B 34.4M 236M 92.08M 1.2B 92.96M 90.94M 3.85B 28M 32.54M 26.28M 24.04M 44.87M 3.08B 45.23M 311M 121M 1.57B 122M 120M 5.06B
Net Debt 162M 188M 152M 139M 260M 17.82B 262M 1.8B 701M 9.1B 708M 692M 29.32B 134M 155M 126M 115M 214M 14.69B 216M 1.48B 578M 7.51B 584M 571M 24.19B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
03/09/26 10.36 -0.58% 1,978
02/09/26 €10.42 +0.19% 2,119
01/09/26 €10.40 +0.39% 1,295
31/08/26 €10.36 +0.78% 3,210
28/08/26 €10.28 0.00% 8,723
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.42EUR
Average target price
15.50EUR
Spread / Average Target
+48.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCGM Stock